|
|
|
| Application of Neoadjuvant Chemotherapy in Sequential Treatment of Stage Ⅲ Esophageal Cancer |
| ZHANG Li, ZHANG Jing, WANG Yuan,et al |
| Dept. of Cardiothoracic Surgery, Qianjiang Central Hospital,Chongqing 409000 |
|
|
|
|
Abstract Objective To investigate the application value of neoadjuvant chemotherapy in sequential treatment of stage Ⅲ esophageal cancer. Methods One hundred patients with stage Ⅲ esophageal cancer were divided into radical radiotherapy group (control group,n=42) and the neoadjuvant sequential chemotherapy group (observation group) according to the treatment methods. The tumor control, treatment effect, safety and quality of life were compared between the two groups. Results The overall remission rate, tumor control rate followed up for 1~3 years, and follow-up survival rate of the observation group were not significantly different compared with those of the control group (P>0.05);Ⅰ~Ⅳ gastrointestinal reaction and the incidence of radiation esophagitis atⅠ~Ⅱgrade of the observation group were lower than those of the control group (P<0.05); There was no significant difference in quality of life between the two groups before treatment (P>0.05). The quality of life scores of the two groups were increased at different times (P<0.05), the quality of life scores of 1~2 year - followed-up were higher than those in the control group (P<0.05). Conclusion The efficacy of neoadjuvant chemotherapy sequential treatment and concurrent radiotherapy /chemotherapy is similar in the treatment of patients with esophageal cancer , but neoadjuvant sequential chemoradiotherapy regimen is safe and can improve the long-term quality of life.
|
|
Received: 27 January 2017
|
|
|
|
|
|
[1] 颜景臣.多西他赛加顺铂动脉灌注化疗配合放疗治疗食管癌术后复发转移的近期疗效[J].医学临床研究,2015,32(6):1168-1171.
[2] 夏阳,周绍新.奥沙利铂联合希罗达治疗晚期食管癌34例临床观察[J].医学临床研究,2011,28(6):1203-1204.
[3] 杨学宁,吴一龙.实体瘤治疗疗效评价标准-RECIST[J].循证医学,2004,4(2):85-90.
[4] 世界卫生组织.抗癌药急性及亚急性毒性反应分度标准(WHO标准)[J]. 癌症,1992,03:254.
[5] 方子燕, 黄龙, 黎功. 2013年美国放射肿瘤学会年会肝脏肿瘤放射治疗研究进展荟萃[J]. 临床肝胆病杂志, 2014, 30(4):383-384.
[6] 郭海强, 丁海龙, 王玉梅. 恶性肿瘤患者生存质量评价的研究现况[J]. 中国卫生统计, 2010, 27(1):104-105.
[7] 薛洋,曾富春,舒骏,等.食管癌术前多西他赛新辅助化疗临床效果观察[J].四川医学,2013,34(9):1298-1300.
[8] 吕会来,张丽,温士旺,等.紫杉醇联合顺铂新辅助化疗用于进展期食管癌的临床观察[J].中国药房,2016,27(18):2500-2502.
[9] 吴铁鹰,刘永兰,冯燕国,等.放疗及联合顺铂、氟尿嘧啶方案同步、序贯治疗中晚期食管癌效果分析[J].中国综合临床,2014,30(5):530-532.
|
| [1] |
. [J]. JOURNAL OF CLINICAL RESEARCH, 2017, 34(5): 1000-1002. |
|
|
|
|
2017, Vol. 34 
